Global ADME – Toxicology Testing Market Update
Add bookmark
Issues with toxicity remain one of the key reasons why promising drug candidates fail to make it beyond the lab – at a cost to both the company and ultimately the patient. A number of industry factors are combining to give companies an added imperative to develop successful drug candidates. The patent cliff is looming ever closer on the horizon as the era of blockbuster drugs come to an end and the costs associated with regulatory compliance are on the rise. It has been estimated that over...
